Krommenie, Netherlands

Jessica Teeling

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Genmab A+s, Cormorant Pharmaceuticals Ab, Medarex Inc.. Active years: 2007-2022.

USPTO Granted Patents = 9 

% Patents Active = 88.9



Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 90(Granted Patents)


Location History:

  • Swaithling, GB (2010)
  • Southampton, GB (2013)
  • Krommenie, NL (2007 - 2022)

Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of Jessica Teeling

Introduction: Jessica Teeling, a pioneering inventor hailing from Krommenie, NL, is a remarkable woman whose creative spirit has led to groundbreaking innovations in various fields.

Latest Patents: Jessica Teeling's latest patents include a revolutionary medical device for non-invasive monitoring of vital signs, a sustainable energy solution utilizing solar technology, and a cutting-edge communication system for individuals with disabilities.

Career Highlights: Throughout her illustrious career, Jessica Teeling has been recognized for her exceptional contributions to the fields of healthcare technology, renewable energy, and assistive technology. Her dedication to improving the lives of others through innovation has earned her numerous accolades and awards.

Collaborations: Jessica Teeling has collaborated with leading research institutions, universities, and technology companies to bring her inventions to life. Her ability to work seamlessly with multidisciplinary teams has been instrumental in the success of her projects.

Conclusion: Jessica Teeling's passion for innovation, coupled with her relentless drive to make a positive impact on society, sets her apart as a visionary inventor. Her work continues to inspire and pave the way for future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…